Firmus goes big with IPO | Marley Spoon’s Ozempic turnaround | Barbie's hefty price tag plus a special guest interview with Andrew Canobi
Firmus, the Aussie AI factory builder, has put a near $44 billion price tag on its IPO…which would make it the second-largest IPO in Australian history.
Marley Spoon, the meal kit company, has seen a major turnaround in sales after selling new meal kits for people on Ozempic.
Mattel, the toy maker of Barbie and Hot Wheels, has received takeover interest from a buyer…which could value the biz at $6 billion USD.
_
Download the free app (App Store): http://bit.ly/FluxAppStore
Download the free app (Google Play): http://bit.ly/FluxappGooglePlay
Daily newsletter: https://bit.ly/fluxnewsletter
Flux on Instagram: http://bit.ly/fluxinsta
Flux on TikTok: https://www.tiktok.com/@flux.finance
—-
The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.
____
This is issued for information purposes only and does not constitute investment or financial product advice. It expresses no views as to the suitability of the services or other matters described in this document as to the individual circumstances, objectives, financial situation, or needs of any recipient. You should assess whether the information is appropriate for you and consider obtaining independent taxation, legal, financial or other professional advice before making an investment decision. Neither Franklin Templeton Australia, nor any other company within the Franklin Templeton group guarantees the performance of any Fund, nor do they provide any guarantee in respect of the repayment of your capital.
Please read the relevant Product Disclosure Statement (PDSs) and any associated reference documents before making an investment decision. In accordance with the Design and Distribution Obligations requirements we maintain Target Market Determinations (TMD) for each of our Funds. All documents can be found via www.franklintempleton.com.au or by calling 1800 673 776.
Issued by Franklin Templeton Australia Limited (ABN 76 004 835 849, AFSL 240827).



